Risk factor
Very poor trading liquidity
Profitability factor
Very favourable analyst view
About
Established in 2005 and headquartered in Warsaw, Poland, Medicalgorithmics S.A. is a prominent provider of cardiac diagnostic solutions, serving markets in Poland, the United States, and globally. The company offers an array of advanced products, including PocketECG, a comprehensive diagnostic system for arrhythmia detection that furnishes detailed ECG signals, data analysis, and exhaustive reports. Another key offering is PocketECG CRS, specifically designed for monitoring patients during cardiac rehabilitation. Its technological portfolio also encompasses ECG TechBot, a software program that utilizes algorithms for the automated analysis and interpretation of ECG signals, and PatchECG, a device enabling single-channel, offline heart monitoring. Additionally, PocketECG IV enhances the core PocketECG device by enabling continuous ECG signal transmission via LTE connectivity. Beyond its innovative devices, Medicalgorithmics S.A. delivers services in information technology, biotechnology, ECG monitoring, and scientific research and development, alongside manufacturing and distributing electro-medical equipment.
Company Valuation
From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. In particular, the stock is 'expensive' on EV/EBITDA, ove
Target Price
The average target price of MDG.WA is 39.7 and suggests 66.6% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to in